-
GSK posts positive Nucala trial results, Darktrace CEO steps down - Sharecast.com
Source: Buzz FX / 06 Sep 2024 03:53:09 America/New_York
Stocks to watch
GSK announced positive results on Friday from a phase three trial evaluating ‘Nucala’, or mepolizumab, in adults with COPD. The FTSE 100 pharmaceuticals giant said the trial showed a statistically significant reduction in th
Read more...